Biotechnology

Techseriesinsight > Blog > News > Biotechnology

June 8, 2026
PRNewswire
Biotechnology, News

MetaVia Presents New Late-Breaking Obesity and Metabolic Data at the ADA 2026 Scientific Sessions Supporting DA-1726 Differentiation and Vanoglipel Combination Potential

MetaVia Inc., a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced the presentation of new late-breaking data highlighting its obesity and metabolic disease portfolio at the American...

June 5, 2026
PRNewswire
Biotechnology, News

Zifo Transforms EHS Policy Management with New AI-Enabled Services Accelerator

Zifo, a leading global enabler of AI and data-driven enterprise informatics for science-driven organizations, today announced a new AI-powered EHS Compliance services accelerator that is purpose-designed for pharma, biotech,...

June 4, 2026
PRNewswire
Biotechnology, News

Global Ergothioneine Market Poised for Accelerated Growth as Scientific Validation and Synthetic Biology Reshape Industry Dynamics

Frost & Sullivan’s latest white paper, Global Ergothioneine Industry Current Landscape and Development Trends, reveals that ergothioneine (EGT) is rapidly transitioning from a niche antioxidant ingredient into a scalable, science-backed...

June 3, 2026
PRNewswire
Biotechnology, News

AMGEN TO PRESENT NEW DATA ACROSS RARE AUTOIMMUNE AND INFLAMMATORY DISEASES AT EULAR 2026

Amgen today announced the presentation of new data across rare autoimmune and inflammatory diseases at the European Alliance of Associations for Rheumatology (EULAR) 2026 Congress, taking place from June...

June 2, 2026
PRNewswire
Biotechnology, News

Phosphorex Names John Rigg Chairman of the Board

Phosphorex, a drug delivery-focused CDMO specializing in lipid nanoparticles, polymeric nanoparticles, and polymeric microspheres, has named John Rigg Chairman of its Board of Directors. Rigg joined the Phosphorex board...

June 1, 2026
PRNewswire
Biotechnology, News

Edgewise Therapeutics Announces Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline

Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that it has entered into a definitive agreement under which Servier, an independent international pharmaceutical group governed...

May 28, 2026
PRNewswire
Biotechnology, News

University of Chicago Urologist Performs First Commercial Vanquish® Water Vapor Ablation Procedures in the State

The procedure was performed on an outpatient basis at the Ingalls Memorial Ambulatory Surgical Center on a patient diagnosed with localized prostate cancer. Vanquish Water Vapor Ablation uses thermal...

May 27, 2026
PRNewswire
Biotechnology, News

CenExel highlights industry-leading capabilities amid growing FDA momentum advancing psychedelic clinical research

The FDA recently announced it is shifting regulatory attention and investment for emerging psychedelic-based therapeutics treating mental health conditions. CenExel Clinical Research is answering this push with expansion to support psychedelic...

May 25, 2026
PRNewswire
Biotechnology, News

CGRP Inhibitors Market to Reach US$12.5 Bn by 2033 Expands with Rising Migraine Awareness and Advanced Targeted Therapies – Persistence Market Research

The global CGRP inhibitors market is expanding rapidly, expected to be valued at around US$ 6.5 billion in 2026 and projected to reach US$ 12.5 billion by 2033, with a CAGR...

May 22, 2026
PRNewswire
Biotechnology, News

Caris Life Sciences to Present 32 Studies at ASCO 2026 Highlighting Advances in Multi-omic Biomarker Research and Real-World Evidence

Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced that Caris, the Caris Precision Oncology Alliance® (Caris POA) and collaborators from more than 60...